These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1954118)

  • 1. Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells.
    Teunissen MB; De Jager MH; Kapsenberg ML; Bos JD
    Br J Dermatol; 1991 Oct; 125(4):309-16. PubMed ID: 1954118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro.
    Dupuy P; Bagot M; Michel L; Descourt B; Dubertret L
    J Invest Dermatol; 1991 Apr; 96(4):408-13. PubMed ID: 1826122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation.
    Teunissen MB; Rongen HA; Bos JD
    J Immunol; 1994 Apr; 152(7):3400-9. PubMed ID: 7511646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM; Katz SI
    J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.
    Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P
    Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
    Chang CH; Furue M; Tamaki K
    Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells.
    Tang A; Udey MC
    J Immunol; 1991 May; 146(10):3347-55. PubMed ID: 1673983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells.
    Bjercke S; Braathen L; Gaudernack G; Thorsby E
    Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.
    Péguet-Navarro J; Moulon C; Caux C; Dalbiez-Gauthier C; Banchereau J; Schmitt D
    Eur J Immunol; 1994 Apr; 24(4):884-91. PubMed ID: 8149959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
    Ozawa H; Aiba S; Nakagawa ; Tagami H
    Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.
    Puré E; Inaba K; Crowley MT; Tardelli L; Witmer-Pack MD; Ruberti G; Fathman G; Steinman RM
    J Exp Med; 1990 Nov; 172(5):1459-69. PubMed ID: 2121888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1991 Apr; 96(4):401-7. PubMed ID: 1826121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function.
    Péguet-Navarro J; Dalbiez-Gauthier C; Dezutter-Dambuyant C; Schmitt D
    Eur J Immunol; 1993 Feb; 23(2):376-82. PubMed ID: 8436173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory capabilities of highly enriched Langerhans cells in vitro.
    Picut CA; Lee CS; Dougherty EP; Anderson KL; Lewis RM
    J Invest Dermatol; 1988 Feb; 90(2):201-6. PubMed ID: 3257515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.